Genzyme and MDA Provide Pompe Families with Free Testing

The biopharmaceutical company will provide first-step Pompe testing (measuring GAA levels in blood) if an MDA clinic physician suspects the disorder

Article Highlights:
  • Biopharmaceutical company Genzyme, with support from MDA, is providing free first-step Pompe testing to those suspected of having the disease.
  • Genzyme's Pompe Disease Registry is collecting patient data for research; enrollment requires a physician's participation.
by Margaret Wahl on June 10, 2013 - 9:35am

Pompe disease (acid maltase deficiency, or GAA deficiency) shares symptoms with several other disorders and, in the absence of specific testing, can sometimes be confused with these other conditions.

The biopharmaceutical company Genzyme, in conjunction with MDA, is offering free first-step testing for Pompe disease. Genzyme is the maker of the Pompe enzyme replacement therapies Myozyme and Lumizyme. (Also see Sizing Up Early Enzyme Replacement for Pompe Disease.)

The test, which can be ordered by any MDA clinic physician who suspects a patient may have Pompe disease, measures levels of the GAA enzyme in blood. If levels are low, confirmatory testing using DNA analysis will be recommended.

In young children, Pompe can resemble such disorders as spinal muscular atrophy, congenital muscular dystrophy and mitochondrial myopathy.

In older children and adults, Pompe can resemble disorders like limb-girdle muscular dystrophy, Becker muscular dystrophy, Duchenne muscular dystrophy, polymyositis, mitochondrial myopathy, SMA, spinal-bulbar muscular atrophy (Kennedy disease) and amyotrophic lateral sclerosis.

In addition, Genzyme’s Pompe Community — a website for families affected by Pompe disease and professionals involved in Pompe research or care — contains information about confirmatory DNA testing for Pompe disease and about the Pompe Registry, a patient registry that requires the participation of a physician. (Also see Pompe Disease Registry on ClinicalTrials.gov.)

Your rating: None Average: 5 (1 vote)
MDA cannot respond to questions asked in the comments field. For help with questions, contact your local MDA office or clinic or email publications@mdausa.org. See comment policy